Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (6840)	7/29/1998 6:40:00 PM
From: John Patterson	Read Replies (1) \| Respond to of 17367

I don't know George, you're probably right. The Merck's of the world will just continue to buy out the bio start ups when they finally hit pay dirt. Look at Somatogen, small investors paid for 12 years and hundreds of millions of dollars of R&D only to have Baxter step in and buy the whole shebang. I guess the officers, directors and top scientists did well, but the average guy that was paying the bills got screwed royally! IMHO one day in the not too distant future the small investor will wake up to this game and then the big boys will have to sink billions into their own R&D. At least with XOMA if I never make a dime I'll have the personal satisfaction of knowing that I contributed something to a drug that may have the power to eradicate an incredible amount of heartache and misery.